(3R,4R)-4-氨基-1-[[4-[(3-甲氧基苯基)氨基]吡咯并[2,1-F][1,2,4]三嗪-5-基]甲基]哌啶-3-醇

(3R,4R)-4-氨基-1-[[4-[(3-甲氧基苯基)氨基]吡咯并[2,1-F][1,2,4]三嗪-5-基]甲基]哌啶-3-醇性质、用途与生产工艺

(3R,4R)-4-氨基-1-[[4-[(3-甲氧基苯基)氨基]吡咯并[2,1-F][1,2,4]三嗪-5-基]甲基]哌啶-3-醇 上下游产品信息

上游原料

下游产品

(3R,4R)-4-氨基-1-[[4-[(3-甲氧基苯基)氨基]吡咯并[2,1-F][1,2,4]三嗪-5-基]甲基]哌啶-3-醇 生产厂家

859853-30-8, (3R,4R)-4-氨基-1-[[4-[(3-甲氧基苯基)氨基]吡咯并[2,1-F][1,2,4]三嗪-5-基]甲基]哌啶-3-醇 相关搜索:

• 抑制剂
• 细胞生物学试剂
• 信号转导通路激酶抑制剂
• 蛋白酪氨酸激酶
• 化合物BMS-690514
• EGFR和VEGFR抑制剂(BMS-690514)
• (3R,4R)-4-氨基-1-((4-(3-甲氧基苯基氨基)吡咯并[1,2-F][1,2,4]三嗪-5-基)甲基)哌啶-3-醇
• (3R,4R)-4-氨基-1-[[4-[(3-甲氧基苯基)氨基]吡咯并[2,1-F][1,2,4]三嗪-5-基]甲基]哌啶-3-醇
• BMS-690514游离碱
• 859853-30-8
• inhibit,ErbB-1,BMS690514,Vascular endothelial growth factor receptor,Epidermal growth factor receptor,Inhibitor,EGFR,BMS 690514,VEGFR,BMS-690514,HER1
• CS-472
• (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo-[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin
• BMS690514/BMS-690514
• BMS-690514(BMS-6690514)
• (3R,4R)-4-Amino-1-[[4-[(3...
• 3-Piperidinol, 4-amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]-, (3R,4R)-
• (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo-[2,1-f][1,2,4]triazin-5-yl]methyl]piperi
• (3R,4R)-4-amino-1-[[4-(3-methoxyanilino)pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol
• BMS-6690514
• (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol
• BMS-690514